FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2573572012> ?p ?o ?g. }

• W2573572012 abstract "Abstract Abstract 465 Immunotherapy may complement the current treatments for lymphomas. The lack of suitable shared lymphoma-associated antigens limits its applicability. Therefore, identification and utilization of novel and more potent tumor-associated antigens, particularly those shared among patients, are urgently needed to improve the efficacy of immunotherapy in the diseases. Recent studies have shown that Dickkopf-1 (DKK1), a secreted protein and Wnt signaling pathway inhibitor, is highly expressed by myeloma and other tumor cells, and is absent from normal tissues and organs except placenta and prostate. In the present study we demonstrated that DKK1 is also overexpressed in mantle cell lymphoma (MCL) and diffuse large B-cell lymphoma (DLBCL). Using DKK1 peptide-pulsed dendritic cells (DCs), we successfully generated HLA-A*0201+ DKK1-specific CTL lines and clones in vitro. These CTLs effectively lysed DKK1+/HLA-A*0201+ lymphoma cell lines Jeko-1 and Granta 519 cells, but not DKK1-/HLA-A*0201+ BJAB, RL and Mino cells nor DKK1+/HLA-A*020- CA46 and Daudi cells. Furthermore, the T-cell clones efficiently killed DKK1+/HLA-A*0201+ primary B-cell lymphoma cells from patients but not lymphoma cells from DKK1–/HLA-A*0201+ patients. HLA-ABC or HLA-A*0201 blocking mAbs significantly inhibited T cell-mediated cytotoxicity against peptide-pulsed T2 cells (P < .01, compared with medium control). No inhibitory effect was observed with mAb against HLA-DR and isotype control IgG. The results indicate that the cytotoxicity was attributed to MHC class I and more specifically, HLA-A*0201-restricted CD8+ CTLs. The CTLs did not kill DKK1–/HLA-A*0201+ DCs, B cells, or PBMCs, These results suggest that the CTLs recognized DKK1 peptides that are naturally processed and presented in the context of HLA-A*0201 molecules on lymphoma cells. To determine the in vivo antitumor activity, NOD-SCID and SCID-hu mice were used for lymphoma cell lines and primary lymphoma cells, respectively. Mice were treated with DKK1-specific CTLs after tumor established in NOD-SCID and SCID-hu mice. Control mice were treated with naïve CD8+ T cells or PBS alone. Tumor burden was measured according to levels of circulating human B2M, and survival rates were determined. Low levels (< 50 ng/ml) of circulating human B2M were detected in group treated DKK1-specific CTLs, while high levels (≥ 150 ng/ml) of circulating human B2M were detected in control mice. In SCID-hu model, X-ray examination showed that established tumors were eradicated in 60% mice treated with DKK1-specific CTLs, while large tumor burdens were found in all control mice. In NOD-SCID model, 40% of mice survived with the treatment of DKK1-specific CTLs. TUNEL assay further confirmed that tumor cells were lysed by DKK1-specific CTLs not naïve CD8+ T cells. These results indicate that DKK1-specific CTLs are able to eradicate established, patient-derived primary B- cell lymphoma in the hosts and adoptive transfer of DKK1-specific CTLs may be used for B-cell lymphoma therapy. Disclosures: No relevant conflicts of interest to declare." @default.
• W2573572012 created "2017-01-26" @default.
• W2573572012 creator A5004439239 @default.
• W2573572012 creator A5027024676 @default.
• W2573572012 creator A5040279346 @default.
• W2573572012 creator A5058744266 @default.
• W2573572012 creator A5064752432 @default.
• W2573572012 creator A5066599847 @default.
• W2573572012 creator A5084566787 @default.
• W2573572012 creator A5084700001 @default.
• W2573572012 date "2009-11-20" @default.
• W2573572012 modified "2023-09-29" @default.
• W2573572012 title "Targeting DKK1 for the Immunotherapy of B-Cell Lymphomas." @default.
• W2573572012 doi "https://doi.org/10.1182/blood.v114.22.465.465" @default.
• W2573572012 hasPublicationYear "2009" @default.
• W2573572012 type Work @default.
• W2573572012 sameAs 2573572012 @default.
• W2573572012 citedByCount "0" @default.
• W2573572012 crossrefType "journal-article" @default.
• W2573572012 hasAuthorship W2573572012A5004439239 @default.
• W2573572012 hasAuthorship W2573572012A5027024676 @default.
• W2573572012 hasAuthorship W2573572012A5040279346 @default.
• W2573572012 hasAuthorship W2573572012A5058744266 @default.
• W2573572012 hasAuthorship W2573572012A5064752432 @default.
• W2573572012 hasAuthorship W2573572012A5066599847 @default.
• W2573572012 hasAuthorship W2573572012A5084566787 @default.
• W2573572012 hasAuthorship W2573572012A5084700001 @default.
• W2573572012 hasConcept C137620995 @default.
• W2573572012 hasConcept C147483822 @default.
• W2573572012 hasConcept C188280979 @default.
• W2573572012 hasConcept C203014093 @default.
• W2573572012 hasConcept C2777491412 @default.
• W2573572012 hasConcept C2777525834 @default.
• W2573572012 hasConcept C2777701055 @default.
• W2573572012 hasConcept C2779338263 @default.
• W2573572012 hasConcept C502942594 @default.
• W2573572012 hasConcept C62478195 @default.
• W2573572012 hasConcept C86803240 @default.
• W2573572012 hasConcept C8891405 @default.
• W2573572012 hasConcept C95444343 @default.
• W2573572012 hasConceptScore W2573572012C137620995 @default.
• W2573572012 hasConceptScore W2573572012C147483822 @default.
• W2573572012 hasConceptScore W2573572012C188280979 @default.
• W2573572012 hasConceptScore W2573572012C203014093 @default.
• W2573572012 hasConceptScore W2573572012C2777491412 @default.
• W2573572012 hasConceptScore W2573572012C2777525834 @default.
• W2573572012 hasConceptScore W2573572012C2777701055 @default.
• W2573572012 hasConceptScore W2573572012C2779338263 @default.
• W2573572012 hasConceptScore W2573572012C502942594 @default.
• W2573572012 hasConceptScore W2573572012C62478195 @default.
• W2573572012 hasConceptScore W2573572012C86803240 @default.
• W2573572012 hasConceptScore W2573572012C8891405 @default.
• W2573572012 hasConceptScore W2573572012C95444343 @default.
• W2573572012 hasLocation W25735720121 @default.
• W2573572012 hasOpenAccess W2573572012 @default.
• W2573572012 hasPrimaryLocation W25735720121 @default.
• W2573572012 hasRelatedWork W2007649924 @default.
• W2573572012 hasRelatedWork W2024812157 @default.
• W2573572012 hasRelatedWork W2025672197 @default.
• W2573572012 hasRelatedWork W2047939960 @default.
• W2573572012 hasRelatedWork W2088951369 @default.
• W2573572012 hasRelatedWork W2104446141 @default.
• W2573572012 hasRelatedWork W2350671599 @default.
• W2573572012 hasRelatedWork W2419853955 @default.
• W2573572012 hasRelatedWork W2580304715 @default.
• W2573572012 hasRelatedWork W2594713144 @default.
• W2573572012 hasRelatedWork W2604705842 @default.
• W2573572012 hasRelatedWork W2740576505 @default.
• W2573572012 hasRelatedWork W2741062235 @default.
• W2573572012 hasRelatedWork W2979534316 @default.
• W2573572012 hasRelatedWork W2990908978 @default.
• W2573572012 hasRelatedWork W2995250047 @default.
• W2573572012 hasRelatedWork W3007105243 @default.
• W2573572012 hasRelatedWork W3013375833 @default.
• W2573572012 hasRelatedWork W3138394257 @default.
• W2573572012 hasRelatedWork W3199818443 @default.
• W2573572012 isParatext "false" @default.
• W2573572012 isRetracted "false" @default.
• W2573572012 magId "2573572012" @default.
• W2573572012 workType "article" @default.